Combo Treatments Promising for HIV-HCV Coinfection
Sustained virologic response for ledipasvir and sofosbuvir; and for daclatasvir and sofosbuvir.
Sustained virologic response for ledipasvir and sofosbuvir; and for daclatasvir and sofosbuvir.
PrEP works when taken, results conclude.
Girl is in remission of infection but she is still infected, not cured.
Two studies show benefits in patients with asymptomatic HIV and in African patients.
Please login or register first to view this content.